Listed

Amphastar Pharmaceuticals, Inc.

AMPHNasdaqCIK 1297184HealthcareFiscal year ends Dec 31

Reports and events: 172 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amphastar Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2020-03-1216:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-20-000003
2019-11-0817:06 ET10-QQuarterly reportPeriod 2019-09-300001297184-19-000044
2019-11-0716:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-19-000041
2019-08-0919:11 ET10-QQuarterly reportPeriod 2019-06-300001297184-19-000038
2019-08-0716:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-19-000033
2019-06-1921:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001297184-19-000030
2019-06-1306:38 ET8-K5.07 Shareholder vote results0001558370-19-005662
2019-05-1019:34 ET10-QQuarterly reportPeriod 2019-03-310001297184-19-000027
2019-05-0916:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-19-000024
2019-04-1816:11 ETDEF 14AProxy statementPeriod 2019-06-120001297184-19-000019
2019-03-1520:42 ET10-KAnnual reportPeriod 2018-12-310001297184-19-000013
2019-03-1416:58 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001297184-19-000009
2019-03-1216:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-19-000003
2018-11-0919:38 ET10-QQuarterly reportPeriod 2018-09-300001297184-18-000050
2018-11-0816:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-18-000046
2018-11-0806:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-18-008890
2018-08-0918:40 ET10-QQuarterly reportPeriod 2018-06-300001297184-18-000043
2018-08-0816:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-18-000041
2018-07-0916:09 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits0001297184-18-000036
2018-06-0820:33 ET8-K5.07 Shareholder vote results0001297184-18-000031
2018-05-1019:13 ET10-QQuarterly reportPeriod 2018-03-310001297184-18-000029
2018-05-0916:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-18-000027
2018-04-1816:09 ETDEF 14AProxy statementPeriod 2018-06-070001297184-18-000020
2018-03-2106:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-18-002285
2018-03-1419:58 ET10-KAnnual reportPeriod 2017-12-310001297184-18-000011
2018-03-1216:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-18-000007
2017-11-0920:27 ET10-QQuarterly reportPeriod 2017-09-300001297184-17-000035
2017-11-0816:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-17-000033
2017-08-0917:21 ET10-QQuarterly reportPeriod 2017-06-300001297184-17-000028
2017-08-0916:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-17-000026
2017-07-2406:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-17-005265
2017-06-0920:34 ET8-K5.07 Shareholder vote results0001297184-17-000020
2017-05-1017:59 ET10-QQuarterly reportPeriod 2017-03-310001558370-17-004032
2017-05-0816:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-17-000017
2017-04-2116:10 ETDEF 14AProxy statementPeriod 2017-06-080001297184-17-000011
2017-03-1518:57 ET10-KAnnual reportPeriod 2016-12-310001297184-17-000007
2017-03-1316:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-17-000003
2016-12-2706:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-16-010637
2016-11-1017:09 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001297184-16-000029
2016-11-0906:31 ET10-QQuarterly reportPeriod 2016-09-300001558370-16-009753
2016-11-0816:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-16-000024
2016-08-0906:07 ET10-QQuarterly reportPeriod 2016-06-300001558370-16-007706
2016-08-0816:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-16-000018
2016-08-0406:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-16-007297
2016-07-0716:18 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001297184-16-000014
2016-06-1016:12 ET8-K5.07 Shareholder vote results0001297184-16-000010
2016-05-1006:22 ET10-QQuarterly reportPeriod 2016-03-310001558370-16-005745
2016-05-0916:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001297184-16-000007
2016-04-2216:02 ETDEF 14AProxy statementPeriod 2016-06-090001297184-16-000003
2016-03-1514:08 ET10-KAnnual reportPeriod 2015-12-310001558370-16-004146

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.